Illness never sleeps, so neither do we
OECD data shows long-term care drive health expenditure, health outcome variations persist
The report provides an overview of overall health status in OECD countries, and how medical progress has contributed to longer and healthier lives for.
EFPIA welcomes the future location of the EMA decision has been made; now the focus must be on transition.
EFPIA congratulates Amsterdam on being selected as the new location for the EMA
Incentives, IP and smaller companies – Case story: Vaxeal
How Vaxeal wants to change patients’ lives by improving health outcomes
1st European Alliance for Personalised Medicine Congress
Personalising Your Health: A Global Imperative!
SafeSciMET Courses on regulatory requirements and guidelines
A course to provide participants with a comprehensive overview of the required in vitro and in vivo nonclinical studies, strategies for the development.
War on Cancer – A patient’s journey
3rd annual conference organised by The Economist Events
Incentivising Research in Areas of High Unmet Medical Need: Lilly’s Alzheimer’s Quest
With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression, avoiding illness and reducing overall costs for healthcare systems